Search This Blog

Thursday, August 1, 2019

Corcept Therapeutics EPS beats by $0.07, beats on revenue

Corcept Therapeutics (NASDAQ:CORT): Q2 Non-GAAP EPS of $0.25 beats by $0.07; GAAP EPS of $0.17 misses by $0.01.
Revenue of $72.26M (+16.0% Y/Y) beats by $1.39M.
Shares +0.18%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)